Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,207.00
-25.00 (-1.12%)
May 1, 2026, 3:30 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 3.95 trillion as of May 5, 2026. Its market cap has increased by 69.70% in one year.
Market Cap
3.95T
Enterprise Value
4.24T
Revenue
2.14T
Ranking
n/a
PE Ratio
13.60
Stock Price
2,207.00
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 3.95T, an increase of 347.85%. That is a compound annual growth rate of 4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.95T | 5.46% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.57T |
| Otsuka Holdings | 5.91T |
| Daiichi Sankyo Company | 4.80T |
| Kyowa Kirin | 1.25T |
| Ono Pharmaceutical | 1.09T |
| Santen Pharmaceutical | 528.52B |
| JCR Pharmaceuticals | 66.24B |
| Perseus Proteomics | 3.24B |